Garcia S. Peter's Insider Trades & SAST Disclosures
Garcia S. Peter's most recent trade in Durect Corp was a trade of 5,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Garcia S. Peter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Durect Corp | Peter S. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2024 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 14 Aug 2024 | 761 | 121,516 | - | 2.6 | 1,963 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 28 Jun 2024 | 1,789 | 122,277 | - | 6.0 | 10,788 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 8.53 per share. | 13 Jun 2024 | 12,000 | 122,348 | - | 8.5 | 102,338 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 8.53 per share. | 13 Jun 2024 | 12,000 | 122,348 | - | 8.5 | 102,338 | Common Stock |
| Alx Oncology Holdings Inc | Garcia Peter S. | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Garcia S. Peter | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 25,000 | 110,348 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Garcia S. Peter | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 1,893 | 85,348 | - | 15.0 | 28,471 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 101,000 | 101,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 32,000 | 86,738 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 887 | 54,738 | - | 7.3 | 6,511 | Common Stock |
| Durect Corp | Peter S. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 893 | 53,723 | - | 11.1 | 9,886 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 29,000 | 55,178 | - | 0 | Common Stock | |
| Durect Corp | Peter S. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 8,363 | 20,813 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 07 Feb 2022 | 8,363 | 24,483 | - | 4.8 | 40,226 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 07 Feb 2022 | 6,637 | 16,120 | - | 4.1 | 27,079 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 6,637 | 89,022 | - | - | Employee Stock Option (right to buy) | |
| Durect Corp | Peter S. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2021 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 7,229 | 60,468 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 18 Oct 2021 | 7,229 | 16,560 | - | 4.1 | 29,494 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 54.33 per share. | 18 Oct 2021 | 2,851 | 13,709 | - | 54.3 | 154,884 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.15 per share. | 18 Oct 2021 | 1,903 | 11,806 | - | 55.2 | 104,958 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.09 per share. | 18 Oct 2021 | 1,437 | 10,369 | - | 56.1 | 80,603 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.30 per share. | 18 Oct 2021 | 438 | 9,520 | - | 58.3 | 25,537 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 57.54 per share. | 18 Oct 2021 | 411 | 9,958 | - | 57.5 | 23,648 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.06 per share. | 18 Oct 2021 | 189 | 9,331 | - | 59.1 | 11,163 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 23 Aug 2021 | 60,000 | 69,331 | - | 4.1 | 244,800 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 40,630 | 95,659 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.09 per share. | 23 Aug 2021 | 19,448 | 22,725 | - | 75.1 | 1,460,278 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 19,370 | 80,468 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.66 per share. | 23 Aug 2021 | 18,060 | 46,181 | - | 72.7 | 1,312,252 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.71 per share. | 23 Aug 2021 | 10,743 | 11,982 | - | 75.7 | 813,317 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 73.57 per share. | 23 Aug 2021 | 4,008 | 42,173 | - | 73.6 | 294,871 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.03 per share. | 23 Aug 2021 | 3,497 | 64,241 | - | 72.0 | 251,906 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.66 per share. | 23 Aug 2021 | 2,616 | 9,366 | - | 76.7 | 200,550 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.85 per share. | 23 Aug 2021 | 1,593 | 67,738 | - | 70.9 | 112,872 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 77.57 per share. | 23 Aug 2021 | 35 | 9,331 | - | 77.6 | 2,715 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 17 Aug 2021 | 10,000 | 19,331 | - | 4.1 | 40,800 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 10,000 | 136,289 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.24 per share. | 17 Aug 2021 | 4,687 | 14,644 | - | 65.2 | 305,757 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 68.34 per share. | 17 Aug 2021 | 2,400 | 9,371 | - | 68.3 | 164,005 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.83 per share. | 17 Aug 2021 | 2,368 | 12,276 | - | 65.8 | 155,892 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.13 per share. | 17 Aug 2021 | 505 | 11,771 | - | 67.1 | 33,899 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 68.62 per share. | 17 Aug 2021 | 40 | 9,331 | - | 68.6 | 2,745 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 28 Jan 2021 | 6,128 | 9,128 | - | 4.1 | 25,002 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 6,128 | 146,289 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 3,000 | 3,000 | - | 19 | 57,000 | Common Stock |
| Alx Oncology Holdings Inc | Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 88,137 | 88,137 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges